0001209191-21-060297.txt : 20211012 0001209191-21-060297.hdr.sgml : 20211012 20211012200252 ACCESSION NUMBER: 0001209191-21-060297 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211011 FILED AS OF DATE: 20211012 DATE AS OF CHANGE: 20211012 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gall Matthew CENTRAL INDEX KEY: 0001816194 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39401 FILM NUMBER: 211319842 MAIL ADDRESS: STREET 1: C/O ITEOS THERAPEUTICS, INC. STREET 2: 139 MAIN STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: iTeos Therapeutics, Inc. CENTRAL INDEX KEY: 0001808865 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 139 MAIN STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 857-204-4583 MAIL ADDRESS: STREET 1: 139 MAIN STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-10-11 0 0001808865 iTeos Therapeutics, Inc. ITOS 0001816194 Gall Matthew 139 MAIN STREET CAMBRIDGE MA 02142 0 1 0 0 Chief Financial Officer Common Stock 2021-10-11 4 M 0 14429 6.16 A 19429 D Stock Option (right to buy) 6.16 2021-10-11 4 M 0 14429 0.00 D 2030-06-18 Common Stock 14429 42388 D This transaction involved a cash exercise of a stock option without a subsequent sale of the underlying shares of common stock. One-fourth of the shares subject to the stock option vested on the one-year anniversary of the vesting commencement date. Thereafter, 1/48 of the shares subject to the stock option vest on a monthly basis following the one-year anniversary of the vesting commencement date, subject to the reporting person's continuous service relationship with the Issuer through each applicable vesting date. /s/ Adi Osovsky, as Attorney-in-Fact 2021-10-12